Andrew Kant Patel, MD

NPI 1275749152ActiveIndividual· Otolaryngology· Portland, OR

Otolaryngology (MD) in Portland, Oregon, trained at University of California, San Francisco School of Medicine (class of 2005). 190 Medicare patients in 2024, $76,778 paid; nearly all of their 1,440 Part D prescriptions were generic (95%). Glaxosmithkline, LLC. was the largest of 2 companies reporting payments in 2025, $239.66 in all, mostly food and beverage.

Overview

NPI	1275749152
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	May 15, 2007
Last updated in NPPES	Nov 14, 2023
Certified by provider	Nov 14, 2023

Specialties and licenses

Taxonomy	Code	License	State
Otolaryngology Primary	207Y00000X	A97587	CA

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Otolaryngology (OR)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	190
Services billed	652 across 54 procedure codes
Paid by Medicare	$76,778

Part D prescriptions in 2024

Prescriptions (claims)	1,440 · 1,933 30-day fills
Patients	358
Total drug cost	$31,639
Generic share	95% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of California, San Francisco School of Medicine
Graduation year	2005
Medicare specialty	Otolaryngology
Telehealth	Offers telehealth